AGX-0073

N/A

Report date: 2022/04/26 16:48:08
NME

Base Information

Drug NameAGX-0073
Drug Alias NameAGX-0073
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cell growth factor receptor inhibitorsDiscoidin domain receptor 1 antagonistsColony stimulating factor 1 receptor inhibitors +[5] 
TargetsStem cell growth factor receptorDiscoidin domain receptor 1Colony stimulating factor 1 receptor +[5] 
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Aojian Biological Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Aojian Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A